McKesson Corporation (MCK)
Distributes medicines and supplies to pharmacies, hospitals, and healthcare providers nationwide
$850.06+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+21.6%
The outlook
MCK is trading at $850.06 with analyst consensus strongly bullish—the average price target sits about 11% above current levels. The stock sits comfortably above both its 50- and 200-day moving averages and roughly midway through its 52-week range, reflecting steady upward positioning. At a trailing P/E of 22.2, the overall data leans constructive.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 15 analysts
Price trendAbove its 50- & 200-day averages
52-week range59% of the way from its 52-week low to high
Price targetAvg target +11% vs current price
Analyst price target
~12-month · 15 analysts$945.47average target+11.2% vs now
Now $850.06
Low $812.00High $1,065.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$999.00
52-wk low
$637.00
50-day avg
$780.97
200-day avg
$833.61
Trailing P/E
22.2